American City Business Journals

Novavax receives first emergency use authorization for its Covid-19 vaccine

Novavax Inc. (NASDAQ: NVAX) said Monday its Covid-19 vaccine has been granted emergency use authorization in Indonesia, the first such approval for the Gaithersburg biotech that has been taking its two-dose, protein-based vaccine through regulatory processes around the globe. “This is a landmark moment for Novavax and our partner, Serum Institute of India, and it is the first of many authorizations that Novavax expects in the coming weeks and months for our vaccine globally,” Novavax President and CEO Stanley Erck said in a statement.


Source link